tldrdailynews.com logo

Hims & Hers halts compounded Wegovy copy amid federal probe

1 min read
Source: statnews.com
Hims & Hers halts compounded Wegovy copy amid federal probe
Photo: statnews.com
TL;DR

Hims & Hers will stop selling a cheaper, compounded version of Novo Nordisk’s obesity pill Wegovy after health officials called for an investigation into possible federal-law violations; the platform had offered a $49/month compounded version, while Novo Nordisk’s Wegovy costs $149–$299/month, as FDA and HHS/DOJ actions move to curb unapproved compounded GLP-1 drugs.

Topics:businesshealth#compounded-drugs#glp-1#health#hims-and-hers#novo-nordisk#wegovy
Share this article
  1. Hims & Hers will stop selling compounded version of Novo’s obesity pill  statnews.com
  2. Hims & Hers pulls copycat weight-loss pill after threats of legal action  CNBC
  3. Hims to stop offering GLP-1 pill after FDA warned of crackdown  Reuters
  4. Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month  investors.hims.com
  5. Hims & Hers to Stop Offering Wegovy Copycat Drug After Regulatory Scrutiny  Barron's

Want the full story? Read the original reporting

Read on statnews.com